Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2313334
Max Phase: Preclinical
Molecular Formula: C36H41N7O11
Molecular Weight: 747.76
Molecule Type: Small molecule
Associated Items:
ID: ALA2313334
Max Phase: Preclinical
Molecular Formula: C36H41N7O11
Molecular Weight: 747.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: [N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1
Standard InChI: InChI=1S/C36H41N7O11/c37-41-38-16-7-17-50-35-28(39-34(49)22-8-3-1-4-9-22)31(47)33(27(20-45)53-35)54-36-32(48)29(30(46)26(19-44)52-36)43-18-25(40-42-43)21-12-14-24(15-13-21)51-23-10-5-2-6-11-23/h1-6,8-15,18,26-33,35-36,44-48H,7,16-17,19-20H2,(H,39,49)/t26-,27-,28-,29+,30+,31-,32-,33-,35-,36+/m1/s1
Standard InChI Key: CMMAHYMRBBHCBK-MZTZKZOHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 747.76 | Molecular Weight (Monoisotopic): 747.2864 | AlogP: 1.70 | #Rotatable Bonds: 15 |
Polar Surface Area: 255.87 | Molecular Species: ACID | HBA: 15 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.56 | CX Basic pKa: | CX LogP: 1.77 | CX LogD: 1.65 |
Aromatic Rings: 4 | Heavy Atoms: 54 | QED Weighted: 0.04 | Np Likeness Score: 0.18 |
1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ.. (2013) Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1., 56 (3): [PMID:23281927] [10.1021/jm301677r] |
Source(1):